Free Trial
OTCMKTS:EKTAY

Elekta (EKTAY) Stock Price, News & Analysis

Elekta logo
$5.06 +0.02 (+0.43%)
As of 07/9/2025 02:53 PM Eastern

About Elekta Stock (OTCMKTS:EKTAY)

Key Stats

Today's Range
$5.04
$5.06
50-Day Range
$4.85
$5.49
52-Week Range
$4.36
$7.13
Volume
709 shs
Average Volume
6,607 shs
Market Capitalization
$1.94 billion
P/E Ratio
101.15
Dividend Yield
2.18%
Price Target
N/A
Consensus Rating
Hold

Company Overview

Elekta Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
65th Percentile Overall Score

EKTAY MarketRank™: 

Elekta scored higher than 65% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Earnings Growth

    Earnings for Elekta are expected to grow by 19.44% in the coming year, from $0.36 to $0.43 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Elekta is 101.15, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.81.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Elekta is 101.15, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 28.02.

  • Price to Book Value per Share Ratio

    Elekta has a P/B Ratio of 2.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Elekta's valuation and earnings.
  • Percentage of Shares Shorted

    0.00% of the float of Elekta has been sold short.
  • Short Interest Ratio / Days to Cover

    Elekta has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elekta has recently decreased by 99.51%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Elekta pays a meaningful dividend of 2.38%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Elekta does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Elekta is 220.00%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Elekta will have a dividend payout ratio of 25.58% next year. This indicates that Elekta will be able to sustain or increase its dividend.

  • Read more about Elekta's dividend.
  • Percentage of Shares Shorted

    0.00% of the float of Elekta has been sold short.
  • Short Interest Ratio / Days to Cover

    Elekta has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Elekta has recently decreased by 99.51%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Elekta has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
  • Insider Buying vs. Insider Selling

    In the past three months, Elekta insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    41.28% of the stock of Elekta is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Read more about Elekta's insider trading history.
Receive EKTAY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elekta and its competitors with MarketBeat's FREE daily newsletter.

EKTAY Stock News Headlines

Google did what!?!?
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
Elekta price target lowered to SEK 57.50 from SEK 64.50 at Barclays
Elekta price target lowered to SEK 57 from SEK 63 at JPMorgan
See More Headlines

EKTAY Stock Analysis - Frequently Asked Questions

Elekta's stock was trading at $5.66 at the beginning of 2025. Since then, EKTAY stock has decreased by 10.7% and is now trading at $5.0565.

Elekta AB (OTCMKTS:EKTAY) announced its earnings results on Wednesday, May, 28th. The company reported $0.11 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.13 by $0.02. The firm had revenue of $503.22 million for the quarter, compared to analyst estimates of $507.19 million. Elekta had a net margin of 1.15% and a trailing twelve-month return on equity of 11.55%.

Shares of EKTAY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/28/2025
Today
7/10/2025
Next Earnings (Estimated)
8/27/2025
Fiscal Year End
4/30/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
N/A
Current Symbol
OTCMKTS:EKTAY
CIK
1451160
Employees
4,718
Year Founded
N/A

Profitability

Trailing P/E Ratio
101.15
Forward P/E Ratio
14.05
P/E Growth
N/A
Net Income
$22.37 million
Pretax Margin
2.72%

Debt

Sales & Book Value

Annual Sales
$1.71 billion
Cash Flow
$0.61 per share
Price / Cash Flow
8.23
Book Value
$2.19 per share
Price / Book
2.31

Miscellaneous

Free Float
225,231,000
Market Cap
$1.94 billion
Optionable
Not Optionable
Beta
1.20

Social Links

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:EKTAY) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners